Budd-Chiari Syndrome in Patient with Primary ThrombocythaemiaTreated with Interferon Alpha Medically Managed by Transjugular Porto-systemic Shunt
Authors:
L. Brunerová 5; H. Bartáková 1; M. Jankovská 2; B. Cieslarová 3; P. Hůlek 4; T. Kozák 2; M. Anděl 5
Authors‘ workplace:
II. interní klinika 3. LF UK a FNKV, Praha 2Oddělení klinické hematologie FNKV, Praha 3I. interní klinika 3. LF UK a FNKV, Praha 4II. interní klinika FN, Hradec Králové 5Laboratoř patofyziologie metabolizmu FNKV, Praha
1
Published in:
Čas. Lék. čes. 2004; : 198-201
Category:
Overview
The case report of a young female patient with personal history of primary thrombocythaemia, treated with interferonalpha, admitted to our medical department for severe abdominal pain, hepatomegaly, ascites and alteration of hepaticfunction is presented. Magnetic resonance imaging showed the picture typical for Budd-Chiari syndrome caused byexternal obstruction of the intrahepatal portion of inferior vena cava. The cause of the syndrome remains uncertain,possibility of the haematogenic infiltration of the liver or venal thrombosis within primary or secondary (interferon- induced) antiphospholipid syndrome is discussed. Liver biopsy could elucidate the exact cause, but it was notperformed for technical problems.
Key words:
Budd-Chiari syndrome, primary thrombocythaemia, interferon alpha, antiphospholipid syndrome,infiltration of organs, TIPS.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Molecular Diagnostics of Malignant B Cell Lymphomas: Detection ofClonality and a Brief Review with our Own Results
- Intelligence Loss in Phatic Disorders
- Budd-Chiari Syndrome in Patient with Primary ThrombocythaemiaTreated with Interferon Alpha Medically Managed by Transjugular Porto-systemic Shunt
- Results of Clinical Study of Patients Suffering from Hodgkin’s Lymphomaafter 25 Years